Insider NameBuy/SellCompany NameTickerAmountShares Change
Nov 08, 2019Nov 12, 2019Patterson Matthew R
CEO
SellAudentes Therapeutics, Inc.BOLD$30$432,780-4.81%
Aug 12, 2019Aug 14, 2019Patterson Matthew R
CEO
SellAudentes Therapeutics, Inc.BOLD$34.04$680,835-6.51%
Feb 25, 2019Feb 27, 2019Patterson Matthew R
CEO
SellAudentes Therapeutics, Inc.BOLD$30$630,000-6.74%
Oct 01, 2018Oct 02, 2018Patterson Matthew R
CEO
SellAudentes Therapeutics, Inc.BOLD$38.16$801,372-10.11%
Sep 18, 2018Sep 20, 2018Patterson Matthew R
CEO
SellAudentes Therapeutics, Inc.BOLD$40$518,080-7.01%
Jul 02, 2018Jul 05, 2018Patterson Matthew R
CEO
SellAudentes Therapeutics, Inc.BOLD$39.55$3M-29.25%
May 21, 2018May 23, 2018Patterson Matthew R
Pres
CEO
SellAudentes Therapeutics, Inc.BOLD$38.15$774,498-10.57%
Apr 02, 2018Apr 05, 2018Patterson Matthew R
Pres
CEO
SellAudentes Therapeutics, Inc.BOLD$30.01$21,009-0.41%
Oct 02, 2017Oct 05, 2017Patterson Matthew R
Pres
CEO
SellAudentes Therapeutics, Inc.BOLD$27.92$698,070-12.70%
Sep 15, 2017Sep 19, 2017Patterson Matthew R
Pres
CEO
SellAudentes Therapeutics, Inc.BOLD$25.06$250,561-5.08%
Jul 12, 2017Jul 15, 2017Patterson Matthew R
Pres
CEO
SellAudentes Therapeutics, Inc.BOLD$20$300,059-7.43%
Sign in to view more
To unlock more features with more data and insights.
Forgot your password?
By continuing, you agree to our Terms of Service and Privacy Policy.